Eosinophilic vasculitis is a rare condition due to vascular damage and infiltration of eosinophils into tissues. Antineutrophil cytoplasmic antibody (ANCA), like perinuclear ANCA (p-ANCA), is common in the context of systemic vasculitis, but its association with illicit drug use is unusual. This case report showcases a distinctive scenario featuring a positive pANCA, prompting a meticulous examination of the interplay between vasculitic manifestations and drug abuse.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.63032/PXUT9006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tuberculosis (TB) is historically the world's deadliest infectious disease. New TB drugs that can avoid pre-existing resistance are desperately needed. The β-lactams are the oldest and most widely used class of antibiotics to treat bacterial infections but, for a variety of reasons, they were largely ignored until recently as a potential treatment option for TB.
View Article and Find Full Text PDFMPO-ANCA-positive eosinophilic granulomatosis with polyangiitis complicated by alveolar hemorrhage treated with mepolizumab as an induction therapy: Case report.
Mod Rheumatol Case Rep
December 2024
Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis preceded by bronchial asthma or allergic sinusitis and accompanied by peripheral blood eosinophilia. Immunosuppressive drugs, such as cyclophosphamide in addition to high-dose glucocorticoids, are recommended for induction of remission in patients with severe EGPA. Although mepolizumab is widely recognized as remission induction therapy in non-fatal/non-organ disabling or relapsed/refractory EGPA, its efficacy and safety in induction of remission for severe cases have been ambiguous.
View Article and Find Full Text PDFOutcomes of Covid-19 Vaccine-Associated Glomerular Diseases (CVAGD) - A Case Series from India.
Indian J Nephrol
July 2024
Department of Nephrology, Madras Medical College, Chennai, Tamil Nadu, India.
Background: Several cases of glomerular diseases following Covid-19 vaccination, especially mRNA vaccines, have been reported. However, there is little data on glomerular diseases associated with the two vaccines widely available in India (Covaxin and Covishield) and their long-term outcomes.
Materials And Methods: This was a prospective observational study conducted between May 2021 and May 2023.
Metabolomic monitoring of chicory during in vitro gastrointestinal digestion and correlation with bioactive properties.
Food Chem
March 2025
Univ. Lille, UMRT 1158 BioEcoAgro, F-59000 Lille, France. Electronic address:
Article Synopsis
- - Chicory is being researched as a functional food, and this study examines how gastrointestinal digestion affects its composition and bioactive properties by creating an aqueous decoction from chicory flour.
- - The study utilized a metabolomic approach to observe how digestion changes specific bioactive molecules across different stages (oral, gastric, and intestinal) and evaluated antioxidant, anti-inflammatory, and hormone regulation effects before and after digestion.
- - Results showed that digestion alters chlorogenic acid and sesquiterpene lactones, enhancing chicory's antioxidant and anti-inflammatory effects, with a notable increase in reactive oxygen species (ROS) scavenging capacity and metabolite activity post-digestion.
Article Synopsis
- CAR T-cell therapy shows strong initial results for treating relapsed refractory multiple myeloma, but most patients eventually relapse, often within 5 months.
- In a study of 139 patients who relapsed after CAR T-cell therapy, different salvage therapies were analyzed, revealing that bispecific antibodies, like talquetamab and teclistamab, had the best overall and complete response rates.
- The presence of extramedullary disease at relapse was linked to poorer outcomes, but bispecific antibodies improved survival rates, suggesting they should be the standard treatment for patients relapsing after CAR T-cell therapy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!